Carolina Armengol

2.2k total citations
32 papers, 940 citations indexed

About

Carolina Armengol is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Carolina Armengol has authored 32 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Hepatology and 11 papers in Molecular Biology. Recurrent topics in Carolina Armengol's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Carolina Armengol is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Carolina Armengol collaborates with scholars based in Spain, France and United States. Carolina Armengol's co-authors include Maria‐Rosa Sarrias, María Sala, Lucía Sanjurjo, Stefano Cairo, Núria Amézaga, Gemma Aran, Aurélie Fabre, Marie‐Annick Buendia, Wei Yu and Charlotte Labalette and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Carolina Armengol

28 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carolina Armengol Spain 18 486 211 181 172 172 32 940
Teruyuki Ueda Japan 10 350 0.7× 226 1.1× 328 1.8× 182 1.1× 135 0.8× 21 830
Xiaoping Geng China 17 320 0.7× 153 0.7× 159 0.9× 205 1.2× 99 0.6× 81 886
Hengjun Gao China 18 399 0.8× 171 0.8× 193 1.1× 253 1.5× 101 0.6× 50 931
Benjamin Ruf United States 14 280 0.6× 192 0.9× 146 0.8× 343 2.0× 298 1.7× 29 869
Yanling Feng China 19 324 0.7× 216 1.0× 89 0.5× 208 1.2× 124 0.7× 70 1.1k
Sallouha Gabbouj Tunisia 18 349 0.7× 163 0.8× 105 0.6× 193 1.1× 132 0.8× 36 793
Idrees Mian United States 11 455 0.9× 202 1.0× 244 1.3× 210 1.2× 79 0.5× 15 1.1k
Abdirashid M. Shire United States 16 537 1.1× 170 0.8× 131 0.7× 161 0.9× 69 0.4× 26 1.0k
Agnieszka Adamek Poland 12 305 0.6× 217 1.0× 185 1.0× 107 0.6× 57 0.3× 33 767
Feng Peng China 15 273 0.6× 146 0.7× 89 0.5× 225 1.3× 118 0.7× 33 767

Countries citing papers authored by Carolina Armengol

Since Specialization
Citations

This map shows the geographic impact of Carolina Armengol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolina Armengol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolina Armengol more than expected).

Fields of papers citing papers by Carolina Armengol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolina Armengol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolina Armengol. The network helps show where Carolina Armengol may publish in the future.

Co-authorship network of co-authors of Carolina Armengol

This figure shows the co-authorship network connecting the top 25 collaborators of Carolina Armengol. A scholar is included among the top collaborators of Carolina Armengol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolina Armengol. Carolina Armengol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Tiankai, Logan G. Spector, Nathan Pankratz, et al.. (2025). Multiancestry Transcriptome-Wide Association Study Identifies Candidate Genes Associated with Hepatoblastoma. Cancer Epidemiology Biomarkers & Prevention. 34(8). 1405–1414.
2.
3.
Li, Qian, Salih Demir, Alexandra Wagner, et al.. (2022). Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma. Cancers. 14(17). 4196–4196. 4 indexed citations
4.
Armengol, Carolina. (2022). Abstract IA29: Present and future of precision oncology in hepatoblastoma. Clinical Cancer Research. 28(17_Supplement). IA29–IA29.
5.
Corujo, David, Roberto Malinverni, Vanesa Valero, et al.. (2022). MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokines. Cell Reports. 39(12). 110988–110988. 10 indexed citations
6.
Farrés, Judith, José Manuel Mas, Maria‐Rosa Sarrias, et al.. (2021). Identification of the most vulnerable populations in the psychosocial sphere: a cross-sectional study conducted in Catalonia during the strict lockdown imposed against the COVID-19 pandemic. BMJ Open. 11(11). e052140–e052140. 5 indexed citations
7.
Mosca, Nicola, Stefano Caruso, Emeric Dubois, et al.. (2021). LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways. Liver Cancer. 11(2). 126–140. 9 indexed citations
8.
Cairo, Stefano, Carolina Armengol, Rudolf Maibach, et al.. (2020). A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients. European Journal of Cancer. 141. 30–39. 17 indexed citations
9.
Bárcena, Cristina, Gemma Aran, Luís Perea, et al.. (2019). CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content. EBioMedicine. 43. 513–524. 34 indexed citations
10.
Marı́n, José J.G., Óscar Briz, Elisa Herráez, et al.. (2018). Molecular bases of the poor response of liver cancer to chemotherapy. Clinics and Research in Hepatology and Gastroenterology. 42(3). 182–192. 68 indexed citations
11.
Sanjurjo, Lucía, Gemma Aran, Núria Amézaga, et al.. (2018). CD5L Promotes M2 Macrophage Polarization through Autophagy-Mediated Upregulation of ID3. Frontiers in Immunology. 9. 480–480. 90 indexed citations
12.
Aguilar‐Bravo, Beatriz, Daniel Rodrigo‐Torres, Sílvia Ariño, et al.. (2018). Ductular Reaction Cells Display an Inflammatory Profile and Recruit Neutrophils in Alcoholic Hepatitis. Hepatology. 69(5). 2180–2195. 57 indexed citations
13.
Aran, Gemma, Lucía Sanjurjo, Cristina Bárcena, et al.. (2018). CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78). The FASEB Journal. 32(7). 3878–3891. 43 indexed citations
14.
Ibáñez, Joan Francesc Julián, et al.. (2017). Spontaneous regression of hepatocellular carcinoma. A case report. Gastroenterología y Hepatología (English Edition). 40(4). 286–288. 2 indexed citations
15.
Armengol, Carolina, Maria‐Rosa Sarrias, & María Sala. (2017). Carcinoma hepatocelular: presente y futuro. Medicina Clínica. 150(10). 390–397. 32 indexed citations
16.
Planas, Ramón, Ramón Bartolí, Rosa M. Morillas, et al.. (2017). HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosis. Digestive and Liver Disease. 50(1). 76–83. 29 indexed citations
17.
Labalette, Charlotte, Yann Nouët, Joëlle Sobczak‐Thépot, et al.. (2008). The LIM-only Protein FHL2 Regulates Cyclin D1 Expression and Cell Proliferation. Journal of Biological Chemistry. 283(22). 15201–15208. 38 indexed citations
18.
Labalette, Charlotte, Yann Nouët, Florence Levillayer, et al.. (2008). The LIM-Only Protein FHL2 Mediates Ras-Induced Transformation through Cyclin D1 and p53 Pathways. PLoS ONE. 3(11). e3761–e3761. 8 indexed citations
19.
Renard, Claire-Angélique, Charlotte Labalette, Carolina Armengol, et al.. (2007). Tbx3 Is a Downstream Target of the Wnt/β-Catenin Pathway and a Critical Mediator of β-Catenin Survival Functions in Liver Cancer. Cancer Research. 67(3). 901–910. 120 indexed citations
20.
Armengol, Carolina, Loreto Boix, Oriol Bachs, et al.. (2003). p27Kip1 is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma. Journal of Hepatology. 38(5). 591–597. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026